Background and Aims: Small bowel visualisation is a complex diagnostic approach, but mandatory for risk stratification and stage-adjusted therapy in Crohn's disease. Current guidelines favour transabdominal ultrasound and small bowel MRI as methods of choice, although their clinical impact in daily practice remains controversial. The aim of this study was to evaluate the diagnostic benefit of small bowel MRI in Crohn's disease according to Montreal Classification, in routine practice. Conclusions: Even in routine practice, small bowel MRI is a powerful and reliable technique in small bowel work-up. Since MRE and MRY presented high diagnostic yields, often detected significant additional information, and significantly caused shifts in Montreal Classification, both techniques are confirmed to be excellent tools in diagnosing and monitoring Crohn's disease in its daily course.
Introduction
Detailed knowledge about disease location, extent, and severity is mandatory for risk stratification and stage-adjusted therapy in Crohn's disease [CD] . Entire small bowel visualisation has prognostic value as the small bowel is most frequently affected by inflammation [more than 80% prevalence in CD], which commonly correlates with complications such as stenosis, fistula, abscess [up to 9-fold] and therefore more severe course of disease. small bowel investigation in CD. 2 Delineation of extraintestinal and transmural inflammation and freely selectable multiplanar imaging with high intrinsic soft-tissue resolution are the significant advantages of MRI. Particularly young patients, who require numerous follow-up examinations, profit from this marginally invasive method without radiation exposure, in view of the relapsing pattern of CD. 3 Restricted availability, difficult examination conditions and the typical contraindications of MRI [claustrophobia, non-MRIcertified implants, adiposity per magna, etc] hinder its application. Furthermore, small bowel MRI is relatively costly and time consuming and owns limited potential to depict superficial mucosal lesions. Adequate luminal distension is crucial for small bowel MRI.
Whereas in magnetic resonance enterography [MRE] the contrast agent is applied by oral ingestion, magnetic resonance enteroclysis [MRY] is performed within a fluid distribution through a nasojejunal tube placed in the distal duodenum. Current literature describes sensitivities and specificities for MRY and MRE concerning the diagnosis of CD as from 87% to 100% [MRY] / 78% to 100% [MRE] ; for the detection of fistulas from 57% to 100% / 75% to 94%; and for identification of stenoses from 55% to 100% / 96%, respectively. 4, 5, 6, 7, 8, 9 Although small bowel disease in CD and its diagnosis by MRI imply exceptional relevance, the evidence base is minor, mostly deriving from small single-centre studies which represent the routine course deficiently; and comparative studies regarding alternative methods are rare and in parts less convincing. The Montreal Classification [MC] of inflammatory bowel disease is an easy, assessable and widely accepted prognostic and therapeutic parameter including the age at diagnosis and the location and behaviour of disease. 10 To our knowledge, only one publication investigated the clinical benefit of small bowel MRI and only one study assessed disease behaviour according to MC. 11, 12 Since we judge small bowel MRI an accurate technique, providing additional intramural and peri-intestinal information, the present study aimed to evaluate the diagnostic impact of small bowel MRI in CD patients in routine clinical course in an extended retrospective analysis. We therefore sought to determine: the diagnostic effect on disease behaviour and location according to MC [1] , whether small bowel MRI is reliable in routine practice [2] in context of compliance and diagnostic yield; and if it offers significant additional diagnostic information [3] . Additionally we investigated whether MRE or MRY should be the preferred method for small bowel assessment in CD [4] since both techniques were performed in this study.
Materials and Methods

Study population
We conducted a retrospective single-centre study of patients undergoing small bowel MRI [ 
Montreal Classification
Assessment of the Montreal Classification [MC] was carried out using the reference standard as baseline control. Thereafter MRI findings were compared with the baseline control and all changes regarding disease behaviour and location were represented as absolute and relative values [as shown in Tables 1 and 2 Before MRI examination, patients were instructed to have low fibre and light meals on the day before and to fast for 8 h before examination. Whereas in magnetic resonance enterography [MRE] the contrast agent was applied by oral ingestion, magnetic resonance enteroclysis [MRY] was performed within a fluid distribution through a nasojejunal tube placed in the distal duodenum. Radioscopy was performed to confirm the correct position of the tube, and Klean-Prep [Norgine, Hamburg, Germany] was prepared according to manufacturer's instructions at room temperature; 1000 ml Klean-Prep was supplied at 100 ml/min and another 1000 ml was administered at 120-130 ml/min. Before MRE, small bowel distension was achieved by drinking 2000 ml of Moviprep [Norgine, Hamburg, Germany]. The MRI scanner Magnetom Symphony Quantum [Siemens Healthcare, Erlangen, Germany] with spine-and body-array coils was used for image acquisition. Supplementary Tables 8 and 9 , available as Supplementary data at ECCOJCC online, illustrate the different sequences performed in this study. In order to reduce breathing artefacts and facilitate bowel distension and bowel loop separation, patients were examined in the prone position if possible. 13 The MRI's field of interest should contain the whole abdomen between diaphragm and symphysis including anorectum; 2040 mg N-butylscopolaminiumbromid [Buscopan, Boehringer Ingelheim, Germany] was injected intravenously to reduce intestinal peristalsis. If necessary another 20 mg of N-butylscopolaminiumbromid could be applied at a later time point.Thereafter 0.1 mmol/kg bodyweight of the contrast agent Gadopentetat-Dimeglumin [Magnevist / Gadovist, Bayer Schering Pharma, Bergkamen, Germany] was injected intravenously at 2.0 ml/s according to manufacturer's instruction. Directly after injection, the second image acquisition was performed representing the arterial phase, and after 30 s the third measurement was executed characterising the venous phase. Total scan time lasted between 30 to 40 min.
Analysis of MRI examinations
After image acquisition, all MRI studies were evaluated by two resident radiologists on a PACS workstation in a consensus decision. Image quality was classified as 'good', 'constricted', and 'bad' according to certain parameters [degree of wall distension, visualisation of intramural and extraintestinal configurations, contrast agent flow, minimisation of breathing artefacts, and adequate selection of slice thickness] though without implementation of a standardised score. As demonstrated in Table 3 , pathological alterations caused by CD and assessed by small bowel MRI were evaluated according to certain parameters: inflammation [mural thickening of at least 3 mm in MRI measured by using digital calliper], bowel wall hyperenhancement [considered pathologically when it had an increased intensity towards adjacent bowel wall segments after injection of contrast agent], bowel wall oedema with or without mural stratification, comb sign, mesenteric fibrofatty proliferation, and lymphadenopathy as illustrated in Figure 2 . Stenosis was defined as luminal narrowing of more than 80% compared with unaffected adjacent bowel segments, and diameter and length of stricturing segments were measured by means of digital callipers [see Table 3 ]. Characteristics of stenoses were defined as inflammatory or fibrotic according to the presence/absence of signal intensity in T2 weighted sequences and contrast enhancement, as shown in Table 3 . Severities of stenoses were evaluated into low-grade, high-grade, and high-grade with prestenotic dilatation. Lesion distribution was defined into the following segments: duodenum, jejunum, ileum [proximal to the terminal ileum], terminal ileum, colon ascendens, colon transversum, colon descendens, and anorectum. The results of the pre-imaging studies [endoscopy, ultrasound, etc] were available for review when the MRI examinations were analysed. Finally both MRI techniques were compared according to an inter-individual comparison. Some patients had MRI examinations with both techniques due to intolerance of one technique as mentioned above.
Diagnostic yield
In order to determine the diagnostic yield of small bowel MRI, MRI findings were evaluated in terms of sensitivity, specificity, positive and negative predictive values according to the above mentioned reference standard, and significant additional diagnostic information. Calculation of diagnostic yield was initially performed for the whole study population [MRY: n = 298 / MRE: n = 49] and secondly only for confirmed or highly suspected IBD patients [MRY: MRY: MR-enteroclysis; MRE, MR-enterography; MRI, sum of all MRY and MRE examinations; X², chi-square test; pre / post, difference before and after small bowel MRI examination; proximal to TI, affected gastrointestinal segments proximal to terminal ileum; TI, terminal ileitis; stricturing, stricturing pattern of disease; penetrating, penetrating pattern of disease; code, code according to Montreal Classification; Δ, difference between pre and post examination; n, absolute number of patients; %, relative number of patients in percent; DIT, decrease in total; IIT, increase in total; IBD, inflammatory bowel disease. 
Statistics
Statistical analysis was performed with SPSS 18-21 [IBM, Armonk, USA].
T-tests and chi-square tests were used to determine statistical significance.
Analysis was considered statistically significant with a p-value in t-tests or X²-tests ≤ 0.05. Patients were included in our analysis regardless of MRI quality and even if they did not fully adhere to the MRI protocol.
Ethical considerations
The study was approved by the institutional review board [registry number 4194-11] and informed consent was obtained from all patients before the examinations. 
Results
Baseline characteristics
In the cohort of 400 patients who underwent small bowel MRI examination, 53 were excluded due to missing MRI reports, so that in summary our study population contained a total of 347 patients [mean age 45 ± 16 years, range 15-81 years, 54% female / 46% male] which is shown in Figure 1 . Overall patient's baseline characteristics were equally balanced between MRI subgroups as displayed in Table 4 3 
Location [L]
Comparing Montreal Classification before and after MRI examination, small bowel MRI led to a significant shift towards a larger extent of disease [higher L-levels: +21.2%, chi-square test: p < 0.05, 95% CI [see Table 1 
Behaviour [B]
Small bowel MRI led to a significant shift of behaviour [B] to more severe types of disease [higher B-levels: +24.6%, chi-square-test: p < 0.05, 95% CI, see Table 2 ]. In MRY, cases of milder disease decreased [-13 .2%] whereas the numbers of more severe types of disease increased [higher B-levels: +25%, chi-square test: p < 0.05, 95% CI]. Analogously, we detected a decrease of milder cases of disease in MRE [-20%] in favour of an increase of more severe types of disease [higher B-levels: +22.9%, chi-square test: p < 0.05, 95% MRY, MR-enteroclysis; MRE, MR-enterography; MRI total, sum of MRY and MRE examinations; n, absolute number of patients; %, relative number of patients in percent; t, t-test; age in years, age in years on the day of examination; BMI, body-mass-index.
Significance: t-test between parameters of MRY-and MRE-subgroups to determine significant differences with 95% CI. 
Discussion
Despite recent innovations of direct and indirect imaging methods as well as further development of existing techniques, small bowel imaging is still a complex diagnostic approach, but useful due to high prevalence of disease, prognostic relevance, and potential complications of small bowel CD, as Thia et al. could prove in a comparable study population of 306 patients. 1 Under study conditions, MRI showed reasonable results, but data from larger cohorts and daily routine practice are missing. To our knowledge this is the first study evaluating small bowel MRI's diagnostic impact on CD patients by assessment of the Montreal Classification before and after examination in routine clinical course with an extended study population. We sought to analyse 400 small bowel MRI examinations, but failed to collect 53 reports of MRI studies. Most indications were known [37%] or suspected [50%] CD, so that in the end 87% of our study patients were examined due to CD [verified in 48%, 167/347]. The cohort is comparable to other CD populations, so that our data seem to be representative in terms of baseline characteristics.
Diagnostic yield
Altogether, high diagnostic accuracies were determined for small bowel MRI, with an overall [n = 347] average sensitivity and specificity of 82.5% and 99.9% [PPV: 99.8% / NPV: 91.1%], respectively, which is consistent with current literature [see Table 7 ]. 8, 13, 14, 15, 16, 17, 18, 19 Additionally, our sub-analysis including only IBD patients [n = 179], which is shown in Supplementary  Tables 15-20 , available as Supplementary data at ECCOJCC online, present an almost similar diagnostic yield, with an overall average sensitivity and specificity for small bowel MRI of 83.4% and 99.7%, respectively [PPV: 99.8% / NPV: 80.6%]. Since small bowel MRI has been primarily developed for the assessment of localisation between the ligament of Treitz and the ileocecal valve, in the present study the highest diagnostic accuracies were recorded in this segment, with an average sensitivity and specificity of 91.7% . Though specificity seems to be very high for the entire small bowel, we assume the values to be substantially accurate. However, whereas the jejunum and proximal ileum lack a simple and robust endoscopic reference standard, conventional ileocolonoscopy confirms inflammation of the terminal ileum particularly reliably. Therefore, MRI does not demonstratee every slight inflammation, but if it once displays a lesion, the result is reliably correct. Furthermore, both techniques presented as powerful and precise in the diagnosis of stenoses, in the specification of length, localisation, clinical relevance [eg ileus], and subtype [fibrotic or inflammatory], with a combination of high average sensitivities and specificities of 78.2% and 100%, respectively [PPV: 100% / NPV: 94.3%, see 
Additional information and Montreal Classification
An important result of this study small bowel MRI was that it caused a significant shift in the Montreal Classification towards more severe patterns of disease. In summary, it led to an increase in the extent of inflammation [higher L-levels; chi-squaretest: p < 0.05, 95% CI] and disease behaviour, ie increase of stricturing/penetrating patterns to more complicated clinical courses [higher B-levels; chi-square test: p < 0.05, 95% CI, see Tables 1  and 2 
MR-enterography or MR-enteroclysis
Being aware that evaluating two diagnostic techniques without performing an intra-individual analysis lacks methodical significance, we nevertheless think that this inter-individual analysis represents the diagnostic performance of MRE/MRY sufficiently. Although image quality is better in MRY, this does not lead to a significant relevance in terms of diagnostic yield. In the present study, both MRY and MRE obtained high diagnostic accuracies across all issues. Certainly, in view of the small number of MRE examinations [n = 49] and limited and equal numbers, an intra-individual analysis would be preferable for comparison. However our hypothesis, that MRY in general achieves a more efficient bowel distension and thus possibly offers the opportunity for a more accurate diagnosis, coincides with prior studies. 7, 8, 19, 21, 22, 23, 24, 25, 26 Nevertheless, MRE achieved a slightly, even though not significantly, higher sensitivity compared with MRY [chi-square test: p > 0.05, 95% CI]. Furthermore, with no nasoduodenal tube, MRE does not require radiation exposure and is less invasive; but the rapid ingestion of large amounts of liquid can be perceived as burden and might cause nausea, particularly in children. 23 Due to the fact that MRE obtained equivalent diagnostic accuracy compared with MRY, but with less time, cost and resourceseffort, higher patient compliance, less invasiveness, no radiation exposure, and less patient burden, we preferentially recommend MRE as other authors do. 7, 8, 19, 23, 24 Future studies, to investigate whether small bowel MRI causes changes in therapy and standardised inflammation activity scores [including thresholds for bowel enhancement], have to be developed for routine practice.
Limitations
The retrospective study design is associated with certain limitations, such as loss of information [missing reports, missing age at onset of disease], unequal group power between MRY [n = 289] and MRE [n = 49], and lack of a standard MRI report protocol and assessment of disease activity, which partly led to difficulties in interpretation. However, to our knowledge, there is no previous study focusing on small bowel MRI's diagnostic impact in daily course of the disease that includes such a large number of patients, which probably represents daily routine practice more accuratelyly than earlier investigations. Furthermore, due to patient selection, consultations between radiologists and gastroenterologists, and the partially non-standardised diagnostic algorithm [small numbers of VCE / enteroscopy] there might be possible causes of statistical bias. Finally, a reference standard consisting of various modalities in small bowel MRI offers considerable, but well-known problems which, in the present study, were solved by determining a reference based on all diagnostic findings as widely used in earlier studies.
Conclusion
As far as we are aware, this study investigated for the first time the diagnostic benefit of small bowel MRI on Crohn's disease phenotype by assessment of Montreal Classification in routine clinical course. MRY and MRE obtained comparably high diagnostic accuracies even in routine practice, affirming their role as powerful and reliable techniques in small bowel investigation of CD patients. MRE should be the favoured technique in small bowel diagnostics of CD patients because of minimal invasiveness. MRI is important in staging and prognostic evaluation of Crohn's disease, since it alters Montreal Classification significantly towards more severe stages of disease. Without performing small bowel MRI, disease behaviour and extent would have been underestimated frequently, thus resulting in false risk stratification, which might be relevant to prognosis of complications and choice of therapy.
